Abstract: To study the protective effect of a novel polysaccharide from Lachnum YM38(LEP-1a) on acute liver injury induced by cisplatin, the ICR mice were randomly divided into five groups: normal group, model group, positive group, LEP-1a low dose group (100 mg/kg), LEP-1a high dose group (200 mg/kg) with six mice in each group. Cisplatin (45 mg/kg) was given to establish an acute liver injury model, and then various physiological indicators of the mice were measured. Results suggested that LEP-1a significantly reduced liver index and the hepatic contents of TG, TC, ALT, AST, AKP, MDA and CAT, and enhanced the SOD activity in mice when compared with the model group. At the same time, it inhibited the expression of inflammatory factors TNF- $ \alpha $ and IL-1 $ \beta $ in serum and reduced inflammatory cell infiltration in liver tissue. Therefore, LEP-1a can alleviate cisplatin-induced acute liver injury through inhibiting oxidative stress and inflammation.
Keywords: Lachnum; polysaccharide; cisplatin; acute liver injury; protective effect